EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSFCAG00000003798
Gene Symbol: MC1R
5 Cross references
159 Possible Orthologues:

Melanocortin 3 Receptor

Ensembl ID : ENSFCAG00000007053
Gene Symbol: MC3R
5 Cross references
139 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSFCAG00000006540
Gene Symbol: MC4R
5 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSFCAG00000031073
Gene Symbol: MTNR1A
5 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSFCAG00000003193
Gene Symbol: MTNR1B
5 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSFCAG00000004615
Gene Symbol: MME
5 Cross references
232 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSFCAG00000029864
Gene Symbol: METAP2
5 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSFCAG00000006712
Gene Symbol: MAPT
5 Cross references
226 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSFCAG00000002234
Gene Symbol: MAPK10
5 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSFCAG00000011912
Gene Symbol: MAPK11
5 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSFCAG00000027782
Gene Symbol: MAPK14
5 Cross references
290 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSFCAG00000014173
Gene Symbol: MAPK3
5 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).